EarningsQ3 2022 Earnings Report

THC Biomed INTL (THCBF) Q3 2022 Earnings Report

65 Followers

THCBF Q3 2022 EPS Results

Actual EPS$0.00

Consensus EPS―

Beat/Miss―

One Year Ago EPS>-$0.01

Actual Revenue$495.03K

Expected Revenue―

Beat/Miss―

YoY Revenue Growth-37.00%

QuarterQ3 2022

Date06/29/2022

TimeAfter Close

Conference CallWednesday, June 29, 2022

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Jun 27, 2024	2024 (Q3)	- / -	―	―
Mar 29, 2024	2024 (Q2)	- / -	―	―
Nov 29, 2023	2024 (Q1)	- / -	0	―
Nov 17, 2023	2023 (Q4)	- / -	―	―
Jun 29, 2023	2023 (Q3)	- / >-0.01	0	―
Apr 03, 2023	2023 (Q2)	- / >-0.01	-0.007	0.00% (0.00)
Dec 29, 2022	2023 (Q1)	- / -	0	―
Nov 25, 2022	2022 (Q4)	- / 0.00	0	―
Jun 29, 2022	2022 (Q3)	- / 0.00	-0.007	―
Apr 01, 2022	2022 (Q2)	- / >-0.01	-0.013	44.44% (<+0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed